Zhejiang Chiral Medicine Chemicals Co. Ltd.
http://www.chiralchem.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Zhejiang Chiral Medicine Chemicals Co. Ltd.
Asia Firmly On The Radar For Actavis/Allergan
For a company that took a step back from China at the beginning of this year, Actavis is again keen to stress that its $66 billion acquisition of Allergan will give it a stronger presence in Asia, including in the key markets of China and India.
Biopharma Dealmaking Quarterly Statistics, Q1 2014
Biopharma financing totaled $9.8 billion, a 53% increase over Q4 2013. Twenty-two M&As were completed with a combined potential value reaching $31.3 billion, and there were 103 biopharma alliances totaling $1.9 billion in potential pre-commercialization value, down 30% from the previous quarter.
Deals Shaping The Medical Industry, March 2014
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced January through February 2014.
Company Information
- Industry
-
Pharmaceuticals
- Generic Drugs
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice